Decreased β-cell mass in Hq mutant mice. by Fabienne T. Schulthess (13268705)

Decreasing RhoB expression increases Ad5wt-mediated transgene expression. by Dragomira Majhen (462312)

Decreasing RhoB expression by siRNA transfection does not change Ad5wt attachment or internalization. by Dragomira Majhen (462312)

Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. by Tra-My Duong-Nu (7300970)

Relative decrease in <i>G</i>′ at <i>f</i>_s = 10 Hz due to 25-fold decrease of various stiffnesses at different prestrains. by Taeyoon Kim (122486)

WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

“…Corresponding densitometry analysis is noted as protein fold expression compared to GAPDH for WT1, p<0.001(***), vFLIP(ns), LANA p<0.05(*), pAKT p<0.05(*), and BCL2 p <0.05(*) using two-sided, unpaired student t-tests. …”

The sialidase inhibitor Neu5Ac2en decreases growth of wt <i>C. canimorsus 5</i> in presence of macrophages. by Manuela Mally (348810)

Subjects:

Binding sites decrease the barrier to folding in hisactophilin. by Shachi Gosavi (160132)

Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

“…<p>DBA iPSCs (labelled as “<i>RPS19/RPL5</i> mutant” or “<i>RPS19/RPL5</i> mutant-”), the corrected DBA cells (expressing a WT version of the mutated gene, <i>RPL5</i> or <i>RPS19</i>, labelled as “<i>RPS19/RPL5</i> mutant <i>RPS19/RPL5</i>” or “corrected <i>RPS19/RPL5</i> mutant”) and the control GFP cells (expressing GFP, labelled as “<i>RPS19/RPL5</i> mutant GFP”) were cultured and the nuclear and cytoplasmic protein was extracted from iPSCs for western blot analysis, and RNA for q-PCR analysis. …”

Suppression of the growth defects in flippase mutants by decreased synthesis of PI. by Kanako Yamagami (703555)

Adhesion strength is decreased in NEDD9−/− MEFs. by Jessie Zhong (171961)

The M650K mutation decreases the firing rate of DRG neurons. by Andreas M. Kist (3106548)

Conditional depletion of RPS0A significantly decreases translation initiation rates. by Tomáš Kouba (153719)

Treatment with wt- or S360A-(A)PC decreases infarct area. by Karin C. A. A. Wildhagen (599651)

Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

“…D) Western blot analysis showing slight change of p-SMAD2 level in the nuclear fractions from <i>RPS19</i> mutant compared to WT and the corrected lines. The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”

Co-expression of WT with M195T–WT decreases the stability of heteromers. by Cinzia Ambrosi (446348)

MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

“…<i>sir1Δ</i> mutant was used as a positive control. <b>(D)</b> Cells of indicated strains were 10-fold serially diluted and then spotted onto SC (left), SD-Ura (middle) and SC+FOA(right) agar plates, the <i>sir1Δ</i> mutant served as a positive control. …”

A647D decreased mexiletine sensitivity of P1332L when coexpressed. by Jie Liu (15128)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…(<b>C</b>) Isoginkgetin treatment leads to a decreased rate of lariat formation (* indicates <i>p</i> = 0.02) without affecting exon ligation or excised lariat degradation (<i>p</i> = 0.22, 0.08), with calculations as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1</a>. …”

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)